VOLUME 68   2007   NUMBER 7

Editorial

989 Twenty Years at the Helm. Alan J. Gelenberg
[PDF]

Publisher Note

991 Twenty Years and Counting.
[PDF]

Original Articles

992 Shared Decision Making and Long-Term Outcome in Schizophrenia Treatment. Johannes Hamann, Rudolf Cohen, Stefan Leucht, Raymonde Busch, and Werner Kissling
[Abstract] [PDF]

998 Are Overweight, Obesity, and Extreme Obesity Associated With Psychopathology? Results From the National Epidemiologic Survey on Alcohol and Related Conditions. [CME] Roger P. Pickering, Bridget F. Grant, S. Patricia Chou, and Wilson M. Compton
[Abstract] [PDF]

1010 Levetiracetam as Adjunctive Therapy for Refractory Anxiety Disorders. Gustavo Kinrys, John J. Worthington, Lisa Wygant, Fernanda Nery, Hannah Reese, and Mark H. Pollack
[Abstract] [PDF]

1014 Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study. James H. Kocsis, Michael E. Thase, Madhukar H. Trivedi, Richard C. Shelton, Susan G. Kornstein, Charles B. Nemeroff, Edward S. Friedman, Alan J. Gelenberg, David L. Dunner, Robert M. A. Hirschfeld, Anthony J. Rothschild, James M. Ferguson, Alan F. Schatzberg, John M. Zajecka, Ronald D. Pedersen, Bing Yan, Saeed Ahmed, Jeff Musgnung, Philip T. Ninan, and Martin B. Keller
[Abstract] [PDF]

1024 Selective Serotonin Reuptake Inhibitors in the Context of Hepatitis C Infection: Reexamining the Risks of Bleeding. Kari A. Martin, Lois E. Krahn, Vijayan Balan, and Marianne J. Rosati
[Abstract] [PDF]

1027 Outcome Following Clozapine Discontinuation: A Retrospective Analysis. James M. Atkinson, Petrina Douglas-Hall, Catrin Fischetti, Anna Sparshatt, and David M. Taylor
[Abstract] [PDF]

1031 Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. Igor Libov, Chanoch Miodownik, Yuly Bersudsky, Tzvi Dwolatzky, and Vladimir Lerner
[Abstract] [PDF]

1038 Cost-Efficacy of Individual and Combined Treatments for Panic Disorder. R. Kathryn McHugh, Michael W. Otto, David H. Barlow, Jack M. Gorman, M. Katherine Shear, and Scott W. Woods
[Abstract] [PDF]

1045 Metabolic Syndrome Among Persons With Schizophrenia and Other Psychotic Disorders in a General Population Survey. Jaana M. Suvisaari, Samuli I. Saarni, Jonna Perälä, Janne V. J. Suvisaari, Tommi Härkänen, Jouko Lönnqvist, and Antti Reunanen
[Abstract] [PDF]

1056 A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids. Pao-Yen Lin and Kuan-Pin Su
[Abstract] [PDF]

1062 Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study. Daniel Souery, Pierre Oswald, Isabelle Massat, Ursula Bailer, Joseph Bollen, Koen Demyttenaere, Siegfried Kasper, Yves Lecrubier, Stuart Montgomery, Alessandro Serretti, Joseph Zohar, and Julien Mendlewicz, for the Group for the Study of Resistant Depression (GSRD)
[Abstract] [PDF]

1071 Efficacy and Tolerability of Adjunctive Ziprasidone in Treatment-Resistant Depression: A Randomized, Open-Label, Pilot Study. David L. Dunner, Jay D. Amsterdam, Richard C. Shelton, Antony Loebel, and Steven J. Romano
[Abstract] [PDF]

1078 Persistent Neuropsychological Deficit in Euthymic Bipolar Patients: Executive Function as a Core Deficit. Maria Mur, Maria J. Portella, Anabel Martínez-Arán, Josep Pifarré, and Eduard Vieta
[Abstract] [PDF]

Focus on Childhood and Adolescent Mental Health

1087 To Medicate or Not to Medicate? Melissa P. DelBello
[PDF]

1088 An Open-Label Study of the Efficacy and Tolerability of Aripiprazole for Children and Adolescents With Tic Disorders. Hanik K. Yoo, Soon-Ho Choi, Subin Park, Hee-Ryung Wang, Jin-Pyo Hong, and Chang-Yoon Kim
[Abstract] [PDF]

1094 A Randomized, Placebo-Controlled Clinical Trial of Bupropion for the Prevention of Smoking in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Michael C. Monuteaux, Thomas J. Spencer, Stephen V. Faraone, Angela M. Wilson, and Joseph Biederman
[Abstract] [PDF]

1102 Positive Childhood Experiences: Resilience and Recovery From Personality Disorder in Early Adulthood. [CME] Andrew E. Skodol, Donna S. Bender, Maria E. Pagano, M. Tracie Shea, Shirley Yen, Charles A. Sanislow, Carlos M. Grilo, Maria T. Daversa, Robert L. Stout, Mary C. Zanarini, Thomas H. McGlashan, and John G. Gunderson
[Abstract] [PDF]

1109 Is Age-at-Onset Criterion Relevant for the Response to Methylphenidate in Attention-Deficit/Hyperactivity Disorder? Marcelo C. Reinhardt, Lucia Benetti, Marcelo M. Victor, Eugenio H. Grevet, Paulo Belmonte-de-Abreu, Stephen V. Faraone, and Luis A. Rohde
[Abstract] [PDF]

Academic Highlights

1117 Advances in the Treatment of Alcohol Dependence. [CME]
[PDF]

1129 Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy, Part 1: Urgent Situations. [CME]
[PDF]

Commentary

1139 The Revised Black Box Warning for Antidepressants Sets a Public Health Experiment in Motion. Andrew C. Leon
[PDF]

ASCP Corner

1142 Dual Dependency on Cocaine and Alcohol in Opiate Addicts: Treatment Options. Tracie Gardner and Thomas Kosten
[PDF]

A Psychiatrist's Diary

1144 Where Experts Are Many. Shyam K. Bhat
[PDF]

Letters To the Editor

1146 Bright Light Therapy for Negative Symptoms in Schizophrenia: A Pilot Study. Wolfgang Aichhorn, Renate Stelzig-Schoeler, Christian Geretsegger, Christoph Stuppaeck, and Georg Kemmler
[PDF]

1146 Dosing of Divalproex Extended Release. David Feifel
[PDF]

  • Reply by Charles L. Bowden

1147 Eosinophilia Indicating Subclinical Clozapine-Induced Pericarditis. Katrin Körtner, Andres H. Neuhaus, Falk Schürer, and Michael Dettling
[PDF]

1148 Quetiapine in Patients With Tourette's Disorder: An Open-Label, Flexible-Dose Study. Jonas L. de Jonge, Danielle C. Cath, and Anton J. L. M. van Balkom
[PDF]

1150 If Buddha Were in Treatment. Anthony Green
[PDF]

  • Reply by Shyam K. Bhat

Book Reviews 1151

Electronic CME Activities

Available through www.psychiatrist.com/toc

e17 Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies. John W. Newcomer and Michael J. Sernyak

e18 Diagnosing ADHD in Adults With Substance Use Disorder: DSM-IV Criteria and Differential Diagnosis. Frances R. Levin and Himanshu P. Upadhyaya

e19 Integrating General Health Care in Private Community Psychiatry Practice. Donald C. Goff and John W. Newcomer